| Filed On | Filing |
|---|---|
| 29 Sep 2026 |
Form 4: 3D Investment Partners Pte. Ltd., Formerly 10% Owner and 1 other
Sold 640,000 shares ($1.73M) |
| 25 Jun 2026 |
Form 4: Nagao Hideki, Director
Granted 44,500 Stock Option (Right to Buy) |
| 25 Jun 2026 |
Form 4: Lemerond Nicole, Director
Granted 44,500 Stock Option (Right to Buy) |
| 25 Jun 2026 |
Form 4: Beaver Carolyn, Director
Granted 44,500 Stock Option (Right to Buy) |
| 20 Jan 2026 |
Form 4: Matsuda Kazuko, Chief Medical Officer
Granted 350,000 Employee Stock Option (Right to Buy) |
| 20 Jan 2026 |
Form 4: Iwaki Yuichi, President and CEO
Granted 450,000 Employee Stock Option (Right to Buy) |
| 20 Jun 2025 |
Form 4: Nagao Hideki, Director
Granted 20,000 Stock Option (Right to Buy) |
| 20 Jun 2025 |
Form 4: Lemerond Nicole, Director
Granted 20,000 Stock Option (Right to Buy) |
| 20 Jun 2025 |
Form 4: Beaver Carolyn, Director
Granted 20,000 Stock Option (Right to Buy) |
| 14 Feb 2025 |
Form 4: Nagao Hideki, Director
Granted 24,500 Stock Option (Right to Buy) |
| 14 Feb 2025 |
Form 4: Matsuda Kazuko, Director
Granted 100,000 Employee Stock Option (Right to Buy) |
| 14 Feb 2025 |
Form 4: Lemerond Nicole, Director
Granted 24,500 Stock Option (Right to Buy) |
| 14 Feb 2025 |
Form 4: Iwaki Yuichi, Director
Granted 100,000 Employee Stock Option (Right to Buy) |
| 14 Feb 2025 |
Form 4: Beaver Carolyn, Director
Granted 24,500 Stock Option (Right to Buy) |
| 10 Jan 2025 |
Form 4: Iwaki Yuichi, Director
Granted 400,000 Employee Stock Option (Right to Buy) |
| 10 Jan 2025 |
Form 4: Matsuda Kazuko, Director
Granted 300,000 Employee Stock Option (Right to Buy) |
| 12 Jun 2024 |
Form 4: Nagao Hideki, Director
Granted 20,000 Stock Option (Right to Buy) |
| 12 Jun 2024 |
Form 4: Lemerond Nicole, Director
Granted 20,000 Stock Option (Right to Buy) |
| 12 Jun 2024 |
Form 4: Beaver Carolyn, Director
Granted 20,000 Stock Option (Right to Buy) |
| 11 Jan 2024 |
Form 4: Iwaki Yuichi, Director
Granted 210,000 Employee Stock Option (Right to Buy) |
Loading...